• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

布拉氏酵母菌预防艰难梭菌诱导的实验性伪膜性结肠炎:一项扫描电子显微镜和微生物学研究。

Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological study.

作者信息

Castex F, Corthier G, Jouvert S, Elmer G W, Lucas F, Bastide M

机构信息

Unité de Recherche en Immunologie, Faculté de Pharmacie, Université de Montpellier I, France.

出版信息

J Gen Microbiol. 1990 Jun;136(6):1085-9. doi: 10.1099/00221287-136-6-1085.

DOI:10.1099/00221287-136-6-1085
PMID:2200843
Abstract

The ability of Saccharomyces boulardii to protect mice against intestinal pathology caused by toxinogenic Clostridium difficile was studied. Different regions of the intestine of experimental mice were prepared for observation by scanning electron microscopy or homogenized for C. difficile enumeration and quantification of toxin A by enzyme immunoassay and toxin B by cytotoxicity. The test group was treated for 6 d with an S. boulardii suspension in drinking water and challenged with C. difficule on day 4. The three control groups were: axenic mice, mice treated with only S. boulardii and mice only challenged with C. difficile. The results showed that: (i) 70% of the mice infected by C. difficile survived when treated with S. boulardii; (ii) the C. difficile-induced lesions on the small and large intestinal mucosa were absent or markedly less severe in S. boulardii-treated mice; and (iii) there was no decrease in the number of C. difficile but rather a reduction in the amount of toxins A and B in S. boulardii-treated mice.

摘要

研究了布拉氏酵母菌保护小鼠免受产毒素艰难梭菌引起的肠道病变的能力。对实验小鼠肠道的不同区域进行处理,以便通过扫描电子显微镜观察,或进行匀浆以对艰难梭菌进行计数,并通过酶免疫测定法定量毒素A,通过细胞毒性法定量毒素B。试验组用饮用水中的布拉氏酵母菌悬液处理6天,并在第4天用艰难梭菌攻击。三个对照组分别为:无菌小鼠、仅用布拉氏酵母菌处理的小鼠和仅用艰难梭菌攻击的小鼠。结果表明:(i)用布拉氏酵母菌处理时,70%感染艰难梭菌的小鼠存活;(ii)在经布拉氏酵母菌处理的小鼠中,艰难梭菌诱导的小肠和大肠黏膜病变不存在或明显较轻;(iii)在经布拉氏酵母菌处理的小鼠中,艰难梭菌数量没有减少,而是毒素A和B的量有所减少。

相似文献

1
Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological study.布拉氏酵母菌预防艰难梭菌诱导的实验性伪膜性结肠炎:一项扫描电子显微镜和微生物学研究。
J Gen Microbiol. 1990 Jun;136(6):1085-9. doi: 10.1099/00221287-136-6-1085.
2
Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.布拉氏酵母菌蛋白酶可抑制艰难梭菌毒素A和B对人结肠黏膜的作用。
Infect Immun. 1999 Jan;67(1):302-7. doi: 10.1128/IAI.67.1.302-307.1999.
3
Kinetics of appearance of intestinal lesions in mice mono-associated with a lethal or non-lethal strain of Clostridium difficile.用致死或非致死艰难梭菌菌株单联小鼠肠道病变出现的动力学
J Med Microbiol. 1994 Feb;40(2):102-9. doi: 10.1099/00222615-40-2-102.
4
Bacillus amyloliquefaciens as prophylactic treatment for Clostridium difficile-associated disease in a mouse model.解淀粉芽孢杆菌作为小鼠模型中艰难梭菌相关性疾病的预防性治疗手段
J Gastroenterol Hepatol. 2015 Aug;30(8):1275-80. doi: 10.1111/jgh.12957.
5
Modulation of Clostridium difficile induced mortality as a function of the dose and the viability of the Saccharomyces boulardii used as a preventative agent in gnotobiotic mice.在悉生小鼠中,作为预防剂使用的布拉氏酵母菌的剂量和活力对艰难梭菌诱导死亡率的调节作用。
Can J Microbiol. 1991 Apr;37(4):315-7. doi: 10.1139/m91-049.
6
Effect of oral Saccharomyces boulardii treatment on the activity of Clostridium difficile toxins in mouse digestive tract.
Toxicon. 1992 Dec;30(12):1583-9. doi: 10.1016/0041-0101(92)90030-9.
7
Saccharomyces boulardii for the prevention of hospital onset Clostridium difficile infection.布拉氏酵母菌预防医院获得性艰难梭菌感染
J Gastrointestin Liver Dis. 2015 Mar;24(1):21-4. doi: 10.15403/jgld.2014.1121.fly.
8
Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters.布拉氏酵母菌对万古霉素治疗后仓鼠中产毒艰难梭菌过度生长的抑制作用
Antimicrob Agents Chemother. 1987 Jan;31(1):129-31. doi: 10.1128/AAC.31.1.129.
9
Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis.艰难梭菌——抗生素相关性结肠炎仓鼠模型中的毒力谱及假定毒力决定因素分析
J Med Microbiol. 1987 Aug;24(1):53-64. doi: 10.1099/00222615-24-1-53.
10
Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants.布拉氏酵母菌用于治疗婴儿艰难梭菌相关性肠道疾病。
J Pediatr Gastroenterol Nutr. 1993 May;16(4):419-25. doi: 10.1097/00005176-199305000-00013.

引用本文的文献

1
Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters.益生菌布拉酵母菌CNCM I-745可预防仓鼠中与暴发相关的艰难梭菌相关性盲肠炎。
Am J Physiol Gastrointest Liver Physiol. 2016 Oct 1;311(4):G610-G623. doi: 10.1152/ajpgi.00150.2016. Epub 2016 Aug 11.
2
Characterization of the Probiotic Yeast Saccharomyces boulardii in the Healthy Mucosal Immune System.健康黏膜免疫系统中益生菌酵母布拉氏酵母菌的特性研究
PLoS One. 2016 Apr 11;11(4):e0153351. doi: 10.1371/journal.pone.0153351. eCollection 2016.
3
Caspase activation as a versatile assay platform for detection of cytotoxic bacterial toxins.
半胱天冬酶激活作为一种通用的细胞毒性细菌毒素检测分析平台。
J Clin Microbiol. 2013 Sep;51(9):2970-6. doi: 10.1128/JCM.01161-13. Epub 2013 Jul 3.
4
Antimicrobial and probiotic properties of yeasts: from fundamental to novel applications.酵母的抗菌和益生菌特性:从基础到新颖的应用。
Front Microbiol. 2012 Dec 19;3:421. doi: 10.3389/fmicb.2012.00421. eCollection 2012.
5
Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.布拉氏酵母菌(Saccharomyces boulardii)用于预防和治疗胃肠道疾病的疗效和安全性。
Therap Adv Gastroenterol. 2012 Mar;5(2):111-25. doi: 10.1177/1756283X11428502.
6
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.布拉氏酵母菌散剂治疗成人患者的系统评价和荟萃分析。
World J Gastroenterol. 2010 May 14;16(18):2202-22. doi: 10.3748/wjg.v16.i18.2202.
7
Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice.布拉酵母菌刺激小鼠肠道对艰难梭菌毒素A的免疫球蛋白A免疫反应。
Infect Immun. 2001 Apr;69(4):2762-5. doi: 10.1128/IAI.69.4.2762-2765.2001.
8
Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.布拉氏酵母菌蛋白酶可抑制艰难梭菌毒素A和B对人结肠黏膜的作用。
Infect Immun. 1999 Jan;67(1):302-7. doi: 10.1128/IAI.67.1.302-307.1999.
9
Brewer's yeast and Saccharomyces boulardii both attenuate Clostridium difficile-induced colonic secretion in the rat.
Dig Dis Sci. 1998 Sep;43(9):2055-60. doi: 10.1023/a:1018811331596.
10
Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum.布拉氏酵母菌蛋白酶可抑制艰难梭菌毒素A对大鼠回肠的作用。
Infect Immun. 1996 Dec;64(12):5225-32. doi: 10.1128/iai.64.12.5225-5232.1996.